Trial Profile
Studies on permeability of the blood brain interface for escitalopram related to the genotype of the ABCB-1 gene -effects on sleep - Escitalopram and sleep
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Generalised anxiety disorder; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Social phobia
- Focus Pharmacodynamics; Pharmacogenomic
- 14 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 16 Sep 2016 New trial record